Viremia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy

অনুরূপ উপাদানগুলি

• Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
  অনুযায়ী: Dorward, J, অন্যান্য
  প্রকাশিত: (2023)
• Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy
  অনুযায়ী: Dorward, J, অন্যান্য
  প্রকাশিত: (2023)
• Clinical outcomes after Viremia among people receiving dolutegravir vs efavirenz-based first-line antiretroviral therapy in South Africa
  অনুযায়ী: Asare, K, অন্যান্য
  প্রকাশিত: (2023)
• Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
  অনুযায়ী: Jienchi Dorward, অন্যান্য
  প্রকাশিত: (2023-09-01)
• Point-of-care viral load testing to manage HIV viraemia during the rollout of dolutegravir-based ART in South Africa: a randomised feasibility study (POwER)
  অনুযায়ী: Dorward, J, অন্যান্য
  প্রকাশিত: (2023)